B. Savastano

TL;DR: Recent evidence supports the use of second-line chemotherapy after progression in patients with good performance status, and perioperative and adjuvant chemotherapy, as well as chemoradiation, can improve outcome of resectable gastric cancer with extended lymph node dissection.

TL;DR: The results confirm that combination of gemcitabine plus Nab-P is effective both in terms of overall response rate, progression-free survival and overall survival, with a good safety profile.

TL;DR: The actual "scenario" of targeted treatments is reviewed, also focusing on the new agents in development for gastric cancer and gastro-esophageal carcinoma, discussing their efficacy and potential applications in clinical practice.

TL;DR: A review of present state-of-the-art in the field of pNETs is presented and it is believed that a multidisciplinary team composed of surgeons, oncologists, endocrinologists, radiation oncologist, radiologists, pathologists and medicals nuclear is required.

TL;DR: Baseline NLR is an independent predictor of survival of patients with mPC receiving palliative chemotherapy and could be useful to develop a simple clinical score to identify a subgroup of Patients with a low chance to benefit from chemotherapy.